Fostering relationships between clinical research and the healthcare industry

To successfully deliver patient benefits and translate IGT technology to the point of care, IGT Network+ engages with the healthcare industry, including large multinationals and UK-based companies.

Industrial stakeholders benefit from the network’s activities by having access to world-leading research, and so being in a position to acquire or negotiate first options on academic ideas and developments. Secondment of our researchers to industrial collaborators will directly benefit the healthcare industry, especially where this can be a mechanism for transitioning EPSRC-funded research into clinical translation through the development of commercial products.

IGT Network+ encourages an entrepreneurial spirit among members, and supports the creation of spin-offs involving established business units across the network partnership, benefitting from mutual experiences and expertise in incubation, seed fund generation and IP management.

Our Business Development Manager


Weng Sie Wong

Connections between IGT Network+ academic partners and industry stakeholders are supported by Dr Weng Sie Wong, Business Development Manager for the UCL Institute of Healthcare Engineering. Weng manages the business development and technology transfer activities of the Institute and UCL’s Translational Imaging Group.